Iradimed (IRMD) Non-Current Deffered Revenue (2013 - 2026)

Iradimed (IRMD) has 14 years of Non-Current Deffered Revenue data on file, last reported at $3.8 million in Q1 2026.

• On a quarterly basis, Non-Current Deffered Revenue rose 17.35% year-over-year to $3.8 million in Q1 2026; TTM through Mar 2026 was $3.8 million, a 17.35% increase from a year earlier, with the FY2025 full-year figure at $4.0 million, up 32.91% from the prior year.
• Non-Current Deffered Revenue for Q1 2026 stood at $3.8 million, down from $4.0 million in the prior quarter.
• Over the last five years, Non-Current Deffered Revenue for IRMD reached as high as $4.0 million in Q4 2025 and fell as low as $1.4 million in Q4 2022.
• Historically, Non-Current Deffered Revenue has averaged $2.8 million across 5 years, with a median of $2.8 million in 2024.
• Across the five-year window, Non-Current Deffered Revenue retreated 29.82% in 2022 and soared 103.14% in 2023, its largest moves.
• Year by year, Non-Current Deffered Revenue stood at $1.4 million in 2022, then surged by 103.14% to $2.8 million in 2023, then advanced by 7.14% to $3.0 million in 2024, then surged by 32.91% to $4.0 million in 2025, then fell by 5.56% to $3.8 million in 2026.
• Per Business Quant data, the three most recent Non-Current Deffered Revenue figures were $3.8 million in Q1 2026, $4.0 million in Q4 2025, and $3.6 million in Q3 2025.